<DOC>
	<DOCNO>NCT01054911</DOCNO>
	<brief_summary>The primary purpose study determine oral ( mouth ) delivery prior tumor removal patient gastrointestinal stromal tumor ( GIST ) result tumor shrinkage allow successful surgery . Therapy administer orally response tumor assess use CTs MRIs .</brief_summary>
	<brief_title>Evaluation Patients With Bulky GIST Using Sunitinib</brief_title>
	<detailed_description>Gastrointestinal stromal tumor ( GIST ) rare cancer affect primarily digestive tract sometimes abdominal cavity adult . The common site stomach follow duodenum small intestine . Surgery mainstay therapy GIST patient whose primary tumor felt resectable . Prior introduction Gleevec , patient inoperable GIST essentially therapeutic option . However , sunitinib trial offer option patient Gleevec resistant intolerant GIST . Clinical benefit demonstrate positive result several sunitinib study vary phase .</detailed_description>
	<mesh_term>Sunitinib</mesh_term>
	<criteria>Patients 19 year old pathologically proven GIST bulky marginally resectable Patients must least one bidimensionally measurable disease site 5 cm great previously irradiate . Bone lesions qualify . Patients must ECOG performance great equal 2 , project survival least three month . Patients must adequate laboratory parameter : Hematologic : Hb &gt; 9.0 ; WBC &gt; 3200 platelet &gt; 100,000/mm3 ; Hepatic : Bilirubin &lt; 2.0 AST within 4 time upper limit normal ; Renal : Creatinine le equal 1.6 eGFR great equal 50 mL/min Men woman childbearing potential must practice strict birth control duration study . Women childbearing potential must nonlactating nonpregnant negative pregnancy test within two week trial registration . The patient , witness , attend physician sign IRBapproved inform consent prior Sunitinib administration . Known brain metastasis significant pleural effusion ascites . Uncontrolled hypertension , diabetes , medical condition . Major surgery within 21 day registration . Patients wtih organ graft exception prior high dose chemotherapy autologous bone marrow ( stem cell ) transplantation . History seizure , central nervous system disorder , dementia , psychosis might preclude adequate inform consent protocol compliance . Prior therapy GIST . A history HIV hepatitis virus infection . Any recent medical condition , opinion investigator , make patient unsuitable study participation . Patients impaired kidney function .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>GIST</keyword>
	<keyword>gastrointestinal stromal tumor</keyword>
	<keyword>gastrointestinal stomach tumor</keyword>
	<keyword>Sunitinib</keyword>
</DOC>